Compounds > verapamil

verapamil and trichostatin a

verapamil has been researched along with trichostatin a in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's1 (25.00)24.3611
2020's2 (50.00)2.80

Authors

AuthorsStudies
Cai, W; Hao, Y; Hu, P; Ma, D; Pan, H; Xie, X; Yu, AD; Yu, J; Yuan, J; Zhang, L; Zhu, H1
Chen, D; Goh, WH; Soh, CK; Wang, H1
Bukhari, S; Cabral, AD; de Araujo, ED; Gawel, JM; Gunning, PT; He, L; Johns, AE; Manaswiyoungkul, P; Nawar, N; Olaoye, OO; Raouf, YS; Sedighi, A; Shouksmith, AE; Sina, D1
Bařinka, C; Benoy, V; Kozikowski, AP; Kutil, Z; Langley, B; Pavlíček, J; Picci, C; Robers, MB; Shen, S; Tavares, MT; Ustinova, K; Van Den Bosch, L; Zhang, G; Zimprich, CA1

Other Studies

4 other study(ies) available for verapamil and trichostatin a

ArticleYear
Small molecule regulators of autophagy identified by an image-based high-throughput screen.
    Proceedings of the National Academy of Sciences of the United States of America, 2007, Nov-27, Volume: 104, Issue:48

    Topics: Autophagy; Calcium Channel Blockers; Cell Line, Tumor; Drug Evaluation, Preclinical; Fluspirilene; Glioblastoma; Green Fluorescent Proteins; Humans; Intracellular Membranes; Loperamide; Microtubule-Associated Proteins; Mycotoxins; Peptides; Phagosomes; Phosphatidylinositol Phosphates; Pimozide; Protein Kinases; Recombinant Fusion Proteins; Sirolimus; Small Molecule Libraries; TOR Serine-Threonine Kinases; Trifluoperazine; Zinc Fingers

2007
Design, Synthesis, and Preclinical Evaluation of Fused Pyrimidine-Based Hydroxamates for the Treatment of Hepatocellular Carcinoma.
    Journal of medicinal chemistry, 2018, 02-22, Volume: 61, Issue:4

    Topics: Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Drug Screening Assays, Antitumor; Heterografts; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Liver Neoplasms; Liver Neoplasms, Experimental; Mice; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Pyrimidines; TOR Serine-Threonine Kinases; Xenograft Model Antitumor Assays

2018
Class I/IIb-Selective HDAC Inhibitor Exhibits Oral Bioavailability and Therapeutic Efficacy in Acute Myeloid Leukemia.
    ACS medicinal chemistry letters, 2020, Jan-09, Volume: 11, Issue:1

    Topics:

2020
Tetrahydroquinoline-Capped Histone Deacetylase 6 Inhibitor SW-101 Ameliorates Pathological Phenotypes in a Charcot-Marie-Tooth Type 2A Mouse Model.
    Journal of medicinal chemistry, 2021, 04-22, Volume: 64, Issue:8

    Topics: Acetylation; Animals; Benzamides; Binding Sites; Charcot-Marie-Tooth Disease; Crystallography, X-Ray; Disease Models, Animal; Half-Life; Histone Deacetylase 6; Histone Deacetylase Inhibitors; Humans; Male; Mice; Mice, Inbred C57BL; Molecular Docking Simulation; Phenotype; Protein Isoforms; Quinolines; Structure-Activity Relationship; Tubulin

2021